Targeting metalloenzymes for therapeutic intervention
AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …
[HTML][HTML] Boron chemicals in drug discovery and development: Synthesis and medicinal perspective
A standard goal of medicinal chemists has been to discover efficient and potent drug
candidates with specific enzyme-inhibitor abilities. In this regard, boron-based bioactive …
candidates with specific enzyme-inhibitor abilities. In this regard, boron-based bioactive …
Arginine metabolism: nitric oxide and beyond
G Wu, SM Morris Jr - Biochemical Journal, 1998 - portlandpress.com
Arginine is one of the most versatile amino acids in animal cells, serving as a precursor for
the synthesis not only of proteins but also of nitric oxide, urea, polyamines, proline …
the synthesis not only of proteins but also of nitric oxide, urea, polyamines, proline …
Boron containing compounds as protease inhibitors
Proteases form one of the largest and more important groups of enzymes. They selectively
catalyze the hydrolysis of peptide bonds and can be divided into four major classes …
catalyze the hydrolysis of peptide bonds and can be divided into four major classes …
Boronic acid compounds as potential pharmaceutical agents
W Yang, X Gao, B Wang - Medicinal Research Reviews, 2003 - Wiley Online Library
Boronic acid compounds have been used, because of their unique structural features, for the
development of potent enzyme inhibitors, boron neutron capture agents for cancer therapy …
development of potent enzyme inhibitors, boron neutron capture agents for cancer therapy …
Arginase as a potential biomarker of disease progression: a molecular imaging perspective
G S. Clemente, A van Waarde, I F. Antunes… - International Journal of …, 2020 - mdpi.com
Arginase is a widely known enzyme of the urea cycle that catalyzes the hydrolysis of L-
arginine to L-ornithine and urea. The action of arginase goes beyond the boundaries of …
arginine to L-ornithine and urea. The action of arginase goes beyond the boundaries of …
Boron-containing inhibitors of synthetases
SJ Baker, JW Tomsho, SJ Benkovic - Chemical Society Reviews, 2011 - pubs.rsc.org
The use of boron in small-molecule pharmaceuticals is increasing. Boron's ubiquitous
occurrence in nature and the recent success of a boronic acid drug (Velcade®) in the clinic …
occurrence in nature and the recent success of a boronic acid drug (Velcade®) in the clinic …
Catalysis by metal-activated hydroxide in zinc and manganese metalloenzymes
DW Christianson, JD Cox - Annual review of biochemistry, 1999 - annualreviews.org
▪ Abstract The metal-activated hydroxide ion is a critical nucleophile in metalloenzymes that
catalyze hydrolysis or hydration reactions. The most common metal used is zinc; …
catalyze hydrolysis or hydration reactions. The most common metal used is zinc; …
Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats
JH Kim, LJ Bugaj, YJ Oh… - Journal of applied …, 2009 - journals.physiology.org
There is increasing evidence that upregulation of arginase contributes to impaired
endothelial function in aging. In this study, we demonstrate that arginase upregulation leads …
endothelial function in aging. In this study, we demonstrate that arginase upregulation leads …
Boron reagents in process chemistry: Excellent tools for selective reductions
ER Burkhardt, K Matos - Chemical reviews, 2006 - ACS Publications
Boranes and borohydride reagents have found utility in synthesis routes to a number of
pharmaceutical and other products. Boron reagents have become increasingly important for …
pharmaceutical and other products. Boron reagents have become increasingly important for …